Wednesday, February 10, 2010, 8:51am EST - Canadian Markets open in 39 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

St. Jude Medical Inc. (STJ)

 On Feb 9: 37.70 USD   0.00 (0.00%)  
MORE ON STJ
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
ST. JUDE MEDICAL (NYSE:STJ) Delayed quote dataEdit
Last Trade: 37.70 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 37.70
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 41.86
Day's Range: N/A - N/A
52wk Range: 31.24 - 41.96
Volume: 0
Avg Vol (3m): 3,377,320
Market Cap: 12.54B
P/E (ttm): 16.70
EPS (ttm): 2.26
Div & Yield: N/A (N/A%)
St. Jude Medical Inc. (STJ)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add STJ to Portfolio   Download Data

HEADLINES
• Earnings Preview: Boston Scientific to report 4Q
AP (Tue 12:46pm)
• Analyst drops price target for heart device makers
AP (Mon, Feb 8)
• New Device Promises To Make Heart Surgery Easier And Safer
Investor's Business Daily (Fri, Feb 5)
• St. Jude sees U.S. launch of Fortify line in mid-2010
at Reuters (Thu, Feb 4)
• St. Jude gets European approval on heart devices
AP (Thu, Feb 4)
• St. Jude Medical Announces European Approval of Smaller, Higher Power ICD and CRT-D Devices with New Heart Failure Monitors
Business Wire (Thu, Feb 4)
• St. Jude Medical announces clinical trial
at bizjournals.com (Wed, Feb 3)
• Celebrating 30 Years of Innovation in Neuromodulation, St. Jude Medical Unveils Latest Product at American Academy of Pain Medicine Annual Meeting
Business Wire (Wed, Feb 3)
• St. Jude Medical Announces IRASE AF Clinical Trial to Evaluate Cardiac Ablation Catheter System for Treatment of Atrial Fibrillation
Business Wire (Wed, Feb 3)
• St. Jude Medical Announces 2010 Annual Investor Conference
Business Wire (Tue, Feb 2)
More Headlines for STJ...
ANALYST
EPS Est (next year) (Dec-10) : 2.74
EPS Est (in 2 years) (Dec-11) : 3.10
Avg Rec (current)*: 2.3
PEG Ratio: 1.06
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodula...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices